Funding Opportunities

[ LSOs | Intramural Awards | Foundations/Other | NIH Announcements ]

Intramural Funding Opportunities

For questions about intramural awards, please contact Meredith Donnelly.

• Deadline: Oct 31, 2024
  UCSF Prostate Cancer Research RFAs
  Announcing three new funding opportunities for research in prostate cancer at UCSF:
  • Prostate Cancer Program Pilot Research Awards
  • Prostate Cancer SPORE Career Enhancement Program
  • Prostate Cancer SPORE Developmental Research Program
• Deadline: Nov 15, 2024
  Upstream Research Center Pilot Grants 
  The Upstream Research Center (co-led by Stanford, UC Davis, and UC San Francisco) has released a third round of requests for pilot proposals to catalyze research aimed at reducing cancer inequities due to structural and social determinants of health, including, but not limited to, structural racism, poverty, income inequality, climate change, food insecurity, social isolation, and housing insecurity.

Foundations/Other Sources

• Deadline: Oct 10, 2024
  Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research
  This program aims to support the development and diversity of talent working in pancreatic cancer research. The proposed project may be basic, translational, clinical, or population sciences related research and must have direct applicability and relevance to the understanding, detection, diagnosis, or treatment of pancreatic cancer.
• Deadline: Oct 15, 2024
  American Cancer Society Clinician Scientist Development Grant
  This award will support full-time faculty members in becoming independent investigators as clinician scientists, and is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research.
• Deadline: Nov 4, 2024
  Melanoma Research Alliance Awards
  The Melanoma Research Alliance has issued a request for proposals for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. This RFP includes: Established Investigator Awards, Young Investigator Awards, Pilot Awards, and Dermatology Career Development Awards.
• Deadline: Nov 4, 2024
  Susan G. Komen ASPIRE award
  The purpose of this program is to enhance the diversity of the breast cancer research workforce by providing established breast cancer scientists with supplemental funding to support research trainees from communities historically minoritized and marginalized in research.
• Deadline: Nov 11, 2024
  The Mark Foundation for Cancer Research Drug Discovery Award
  This program aims to accelerate the translation of academic discoveries into new cancer therapies, offers investigators up to $1 million to discover and progress a new therapeutic agent into preclinical development. Grantees also benefit from the expertise of seasoned biopharma R&D scientists as they navigate the complex path to developing a new therapeutic agent.
• Deadline: Nov 12, 2024
  NCCN and Taiho Request for Proposals (RFP) Opportunity: Phase I/II Clinical Trials of Tipiracil/Trifluridine (TAS-102) and/or Futibatinib (TAS-120) for Gastrointestinal Cancers
  National Comprehensive Cancer Network (NCCN) is collaborating with Taiho Oncology, Inc. to offer a new funding opportunity for the design and performance of clinical studies of Tipiracil/Trifluridine (FTD/TPI) and/or Futibatinib in the treatment of gastrointestinal cancers.